Pepaxto

Generic name: melphalan Flufenamide
Dosage form: lyophilized powder for injection
Drug class: Alkylating agents

Usage of Pepaxto

Pepaxto is a prescription medicine used in combination with the medicine Dexamethasone to treat adults with multiple myeloma who did not respond to or stopped responding to at least four prior medicines including at least one proteasome inhibitor, one immunomodulatory agent and one CD38-directed antibody. Pepaxto is not for use to prepare for transplant. It is not known if this medicine is safe and effective in children.

Pepaxto side effects

Pepaxto may cause serious side effects, including:

Low blood cell counts are common with Pepaxto and can be serious. Your healthcare provider will do blood tests as needed to check your blood cell counts during your treatment.

Low platelet counts: Tell your healthcare provider right away if you have a bleeding or bruising under the skin.

Low red blood cell counts: Tell your healthcare provider if you are feeling weak, tired or you get tired easily, you look pale, or if you feel short of breath.

Low white blood cell counts: A low white blood cell count increases the risk of infections.

Infections. Pepaxto can cause infections that have led to death. Tell your healthcare provider right away if you develop new or worsening signs or symptoms of infection such as fever, chills, cough, pain, or burning during urination during treatment with Pepaxto.

Secondary cancers. New cancers such as myelodysplastic syndromes or acute leukemia have happened in people with multiple myeloma who have received Pepaxto. Your healthcare provider will monitor you for new cancers.

Your healthcare provider may change your dose, stop your treatment for a period of time, or completely stop your treatment if you have certain side effects.

Pepaxto may cause fertility problems in males and females, which may affect your ability to have children. Talk with your healthcare provider if you have concerns about fertility.

The most common side effects include, low blood cell counts, fatigue, nausea, diarrhea, fever, and cold-like symptoms (respiratory tract infection).

These are not all of the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before taking Pepaxto

Do not receive Pepaxto if you have a history of a severe allergic reaction to melphalan flufenamide or melphalan.

Relate drugs

How to use Pepaxto

Pepaxto is given to you by your healthcare provider into your vein through intravenous (IV) infusion over 30 minutes.

Pepaxto is usually given 1 time every 28 days.

Your healthcare provider will decide how many treatments you need.

Your healthcare provider will do blood tests before and during your treatment to check for side effects.

Your healthcare provider may prescribe medicines to help prevent nausea before your infusion and during treatment.

What other drugs will affect Pepaxto

Other drugs may interact with melphalan flufenamide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.